Bio View

Bio View Current Assets

The Current Assets of Bio View (BIOV.TA) as of Oct 18, 2026 is 13.58 M ILS. In the previous year, Current Assets was 25.01 M ILS — a change of -45.71% (lower).

Current Assets

13.58 MILS

YoY

-45.71%

Last updated:

Current Assets of Bio View is 2025 13.58 M ILS. Current Assets of Bio View was 2024 25.01 M ILS. It decreases by -45.71% lower compared to the previous year.

The Bio View Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
26.15 M ILS
Jan 1, 2019
27.95 M ILS
Jan 1, 2020
25.98 M ILS
Jan 1, 2021
29.22 M ILS
Jan 1, 2022
31.59 M ILS
Jan 1, 2023
33.04 M ILS
Jan 1, 2024
25.01 M ILS
Jan 1, 2025
13.58 M ILS
The Bio View Current Assets history
YEARCurrent AssetsYoY
13.58 MILS-45.71%
25.01 MILS-24.31%
33.04 MILS+4.59%
31.59 MILS+8.10%
29.22 MILS+12.49%
25.98 MILS-7.08%
27.95 MILS+6.88%
26.15 MILS-4.89%
27.50 MILS-14.41%
32.13 MILS+22.11%
26.31 MILS+8.98%
24.14 MILS+17.22%
20.60 MILS-7.67%
22.31 MILS+0.07%
22.29 MILS+143.40%
9.16 MILS+0.45%
9.12 MILS-27.99%
12.66 MILS-1.02%
12.79 MILS-21.58%
16.31 MILS+293.96%
4.14 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

Current Assets of Bio View is 13.58 M ILS in 2025.

Current Assets of Bio View changed from 25.01 M ILS to 13.58 M ILS, representing a -45.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Bio View since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Bio View historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bio View

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bio View